ICU Medical Future Growth

Future criteria checks 3/6

ICU Medical is forecast to grow earnings and revenue by 73.7% and 0.5% per annum respectively. EPS is expected to grow by 72.5% per annum. Return on equity is forecast to be 6.8% in 3 years.

Key information

73.7%

Earnings growth rate

72.5%

EPS growth rate

Medical Equipment earnings growth	12.5%
Revenue growth rate	0.5%
Future return on equity	6.8%
Analyst coverage	Good
Last updated	11 Dec 2024

Recent future growth updates

ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

Nov 15

Recent updates

ICU Medical: What's Ahead In 2025

Jan 02

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Dec 06

ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

Nov 15

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Oct 01

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

Aug 18

ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

Aug 07

ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult

Jun 27

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Jun 23

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

May 09

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

Apr 26

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Mar 31

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

Jan 31

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Jan 04

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Oct 28

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Oct 07

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Aug 08

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

Jul 20

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jun 08

Earnings and Revenue Growth Forecasts

NasdaqGS:ICUI - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2027	2,280	155	N/A	N/A	1
12/31/2026	2,406	75	N/A	323	6
12/31/2025	2,336	2	N/A	291	6
12/31/2024	2,329	-112	N/A	134	6
9/30/2024	2,340	-111	160	255	N/A
6/30/2024	2,304	-71	157	254	N/A
3/31/2024	2,257	-59	75	171	N/A
12/31/2023	2,259	-30	73	166	N/A
9/30/2023	2,249	-28	-13	73	N/A
6/30/2023	2,294	-48	-44	40	N/A
3/31/2023	2,306	-46	-110	-20	N/A
12/31/2022	2,280	-74	-161	-62	N/A
9/30/2022	2,043	-39	-78	22	N/A
6/30/2022	1,781	5	-1	99	N/A
3/31/2022	1,541	41	124	215	N/A
12/31/2021	1,316	103	186	268	N/A
9/30/2021	1,296	109	175	263	N/A
6/30/2021	1,279	103	168	260	N/A
3/31/2021	1,260	94	146	235	N/A
12/31/2020	1,271	87	122	223	N/A
9/30/2020	1,266	81	98	193	N/A
6/30/2020	1,255	83	73	168	N/A
3/31/2020	1,264	87	60	162	N/A
12/31/2019	1,266	101	-4	102	N/A
9/30/2019	1,291	73	3	103	N/A
6/30/2019	1,311	47	1	104	N/A
3/31/2019	1,359	55	57	160	N/A
12/31/2018	1,400	29	59	160	N/A
9/30/2018	1,430	86	90	195	N/A
6/30/2018	1,446	86	N/A	242	N/A
3/31/2018	1,417	18	N/A	210	N/A
12/31/2017	1,293	69	N/A	154	N/A
9/30/2017	1,018	28	N/A	91	N/A
6/30/2017	772	47	N/A	19	N/A
3/31/2017	537	101	N/A	-4	N/A
12/31/2016	379	63	N/A	90	N/A
9/30/2016	372	59	N/A	84	N/A
6/30/2016	361	56	N/A	77	N/A
3/31/2016	348	53	N/A	68	N/A
12/31/2015	340	45	N/A	64	N/A
9/30/2015	329	47	N/A	61	N/A
6/30/2015	321	37	N/A	61	N/A
3/31/2015	316	29	N/A	61	N/A
12/31/2014	307	26	N/A	66	N/A
9/30/2014	306	32	N/A	72	N/A
6/30/2014	311	37	N/A	69	N/A
3/31/2014	311	38	N/A	68	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ICUI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: ICUI is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ICUI is expected to become profitable in the next 3 years.

Revenue vs Market: ICUI's revenue (0.5% per year) is forecast to grow slower than the US market (8.8% per year).

High Growth Revenue: ICUI's revenue (0.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ICUI's Return on Equity is forecast to be low in 3 years time (6.8%).

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/07 23:03
End of Day Share Price	2025/02/07 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ICU Medical, Inc. is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
James Terwilliger	Benchmark Company
Lawrence Solow	CJS Securities, Inc.
Jeffrey Cohen	C. K. Cooper & Company, Inc.

ICU Medical Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

ICU Medical, Inc. Revises Earnings Guidance for the Year 2024

Consensus EPS estimates fall by 17%

Price target increased by 12% to US$174

Price target increased by 7.6% to US$162

Price target increased by 10% to US$155

Recent updates

ICU Medical: What's Ahead In 2025

President recently sold US$350k worth of stock

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Chief Operating Officer notifies of intention to sell stock

ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

ICU Medical, Inc. Revises Earnings Guidance for the Year 2024

CEO & Chairman of the Board notifies of intention to sell stock

ICU Medical, Inc. to Report Q3, 2024 Results on Nov 12, 2024

Consensus EPS estimates fall by 17%

Price target increased by 12% to US$174

ICU Medical, Inc. Appoints Daniel Woolson as President

CEO & Chairman of the Board exercised options and sold US$1.1m worth of stock

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Price target increased by 7.6% to US$162

Price target increased by 10% to US$155

CEO & Chairman of the Board exercised options and sold US$896k worth of stock

Insider recently sold US$408k worth of stock

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

CEO & Chairman of the Board exercised options and sold US$807k worth of stock

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. Updates Earnings Guidance for the Fiscal Year 2024

ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

Insufficient new directors

ICU Medical, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Now 21% undervalued

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Dynamic Index

ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Chief Operating Officer recently sold US$1.3m worth of stock

Consensus EPS estimates fall by 65%

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

ICU Medical, Inc., Annual General Meeting, May 15, 2024

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

CEO & Chairman of the Board exercised options and sold US$262k worth of stock

ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director

Director notifies of intention to sell stock

Chief Operating Officer recently sold US$1.5m worth of stock

ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Chairman of the Board exercised options and sold US$5.4m worth of stock

ICU Medical, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 Health Care (Sector)

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 24% to US$154

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

ICU Medical, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Chief Operating Officer recently sold US$884k worth of stock

Chief Operating Officer notifies of intention to sell stock

ICU Medical Inc. Receives FDA Clearance for Plum Duo Infusion Pump and LifeShield Infusion Safety Software

Icu Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

ICU Medical, Inc. to Report Q2, 2023 Results on Aug 07, 2023

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Now 23% undervalued after recent price drop

CEO & Chairman of the Board notifies of intention to sell stock

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Small Cap Comp Growth Index

Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

CEO & Chairman of the Board exercised options and sold US$3.9m worth of stock

First quarter 2023 earnings: EPS misses analyst expectations

Corporate VP notifies of intention to sell stock

Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

CEO & Chairman of the Board exercised options and sold US$1.5m worth of stock